Gene editing therapy ready for cardiovascular diseases: opportunities, challenges, and perspectives

Gene editing nucleases (GENs), represented by CRISPR/Cas9, have become major tools in biomedical research and offer potential cures for many human diseases. Gene editing therapy (GETx) studies in animal models targeting genes such as proprotein convertase subtilisin/kexin type 9 (PCSK9), apolipoprot...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jun, Ren, Zhuoying, Xu, Jie, Zhang, Jifeng, Chen, Y. Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471110/
https://www.ncbi.nlm.nih.gov/pubmed/37724071
http://dx.doi.org/10.1515/mr-2021-0010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471110/
https://www.ncbi.nlm.nih.gov/pubmed/37724071
http://dx.doi.org/10.1515/mr-2021-0010

Ejemplares similares